Moscow, August 3, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...

Research and Development institute “ChemRar” has created a unique platform for innovation drug discovery against novel ...

Moscow, July 14, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group, supported by the Russian ...

RDIF and ChemRar have produced the first 100,000 courses of Avifavir In June Avifavir was delivered across Russia’s ...

Moscow, June 11, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar ...

Moscow, June 8, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group ...

Avifavir is one of the two registered COVID-19 drugs in the world Avifavir is the first drug registered in Russia ...

Avifavir is the first direct-acting antiviral drug registered in Russia that has proven effective against COVID-19 in ...

Median elimination of the virus in four days compared to nine days with standard therapy, according to the study ...

Moscow, May 13, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group ...

Russia is set to test the antiviral drug Favipiravir as a treatment for COVID-19 following "excellent results" in ...